Клинические ответы Cochrane
Cochrane Clinical Answers (CCAs) provide a readable, digestible, clinically focused entry point to rigorous research from Cochrane systematic reviews. They are designed to be actionable and to inform decision making at the point of care and have been added to relevant sections of the main Best Practice text.
- In adults with acute bronchitis who do not have any other underlying pulmonary disease or acute respiratory illness, what are the benefits and harms of beta2-agonists?
- What are the effects of using C‐reactive protein (CRP) to guide antibiotic prescribing for adults with acute respiratory infection in primary care?
- How do point‐of‐care diagnostic tests for acute respiratory infection affect antibiotic prescribing behavior in primary care?
- How do communication strategies affect antibiotic prescribing behavior for acute respiratory infection in primary care?
- For people with respiratory infection, how do delayed compare with immediate or no antibiotic prescriptions?
- In people with acute bronchitis, is there randomized controlled trial evidence to support the use of antibiotics?
- What are the benefits and harms of azithromycin compared with amoxicillin or amoxicillin/clavulanic acid in people with acute lower respiratory tract infections?
Использование этого контента попадает под действие нашего заявления об отказе от ответственности